{"id":538782,"date":"2021-04-15T18:42:01","date_gmt":"2021-04-15T18:42:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=538782"},"modified":"2021-04-15T18:42:01","modified_gmt":"2021-04-15T18:42:01","slug":"egg-allergy-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-aimmune-therapeutics-dbv-technologies-asit-biotechand-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/egg-allergy-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-aimmune-therapeutics-dbv-technologies-asit-biotechand-others_538782.html","title":{"rendered":"Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others."},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585720511.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585720511.jpeg\" alt=\"Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Egg Allergy Pipeline<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\"><strong>Egg Allergy<\/strong> develops when immune system of the body becomes sensitized and overreacts to proteins in egg whites and\/or yolks. When eggs are eaten, the body recognizes the protein as a foreign substance and sends out chemicals to provide protection against it. Those chemicals cause the symptoms of an allergic reaction. According to the experts, about 2 percent of children are allergic to eggs. Although, studies show that about 70 percent of children with an Egg Allergy will recover from the condition by age of16.<\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s,&nbsp;<strong>&ldquo;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/egg-allergy-pipeline-insight?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Egg Allergy Pipeline<\/a> Insight, 2021,&rdquo;<\/strong>&nbsp;report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Egg Allergy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for free sample report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/egg-allergy-pipeline-insight?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/egg-allergy-pipeline-insight<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of Egg Allergy Companies are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Aimmune Therapeutics<\/li>\n<li>DBV Technologies<\/li>\n<li>ASIT Biotech<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for free sample report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/egg-allergy-pipeline-insight?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/egg-allergy-pipeline-insight<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Current Egg Allergy Treatment Scenario and Egg Allergy Emerging Therapies:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>How many companies are developing Egg Allergy drugs?<\/li>\n<li>How many Egg Allergy drugs are developed by each company?<\/li>\n<li>How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Egg Allergy?<\/li>\n<li>What are the key collaborations (Industry&ndash;Industry, Industry&ndash;Academia), Mergers and acquisitions, licensing activities related to the Egg Allergy therapeutics?<\/li>\n<li>What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?<\/li>\n<li>What are the clinical studies going on for Egg Allergy and their status?<\/li>\n<li>What are the key designations that have been granted to the emerging drugs?<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/egg-allergy-pipeline-insight?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">Egg Allergy therapies<\/a> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>AR201 Powder<\/li>\n<li>Viaskin Egg (Egg Allergy Immunotherapy)<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for free sample report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/egg-allergy-pipeline-insight?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\">https:\/\/www.delveinsight.com\/sample-request\/egg-allergy-pipeline-insight<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">Introduction<\/p>\n<p style=\"text-align: justify;\">Executive Summary<\/p>\n<p style=\"text-align: justify;\">Egg Allergy: Overview<\/p>\n<p style=\"text-align: justify;\">Pipeline Therapeutics<\/p>\n<p style=\"text-align: justify;\">Therapeutic Assessment<\/p>\n<p style=\"text-align: justify;\">Egg Allergy &ndash; DelveInsight&rsquo;s Analytical Perspective<\/p>\n<p style=\"text-align: justify;\">In-depth Commercial Assessment<\/p>\n<ul style=\"text-align: justify;\">\n<li>Egg Allergy companies&rsquo; collaborations, Licensing, Acquisition -Deal Value Trends<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Egg Allergy Collaboration Deals<\/p>\n<p style=\"text-align: justify;\">Late Stage Products (Phase III)<\/p>\n<ul style=\"text-align: justify;\">\n<li>Comparative Analysis<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Drug name: Company name<\/p>\n<p style=\"text-align: justify;\">Drug profiles in the detailed report&hellip;..<\/p>\n<p style=\"text-align: justify;\">Mid Stage Products (Phase II)<\/p>\n<ul style=\"text-align: justify;\">\n<li>Comparative Analysis<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">AR201: Aimmune Therapeutics<\/p>\n<p style=\"text-align: justify;\">Drug profiles in the detailed report&hellip;..<\/p>\n<p style=\"text-align: justify;\">Pre-clinical and Discovery Stage Products<\/p>\n<ul style=\"text-align: justify;\">\n<li>Comparative Analysis<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Viaskin Egg (Egg Allergy immunotherapy): DBV Technologies<\/p>\n<p style=\"text-align: justify;\">Drug profiles in the detailed report&hellip;..<\/p>\n<p style=\"text-align: justify;\">Inactive Products<\/p>\n<p style=\"text-align: justify;\">Egg Allergy Key Companies<\/p>\n<p style=\"text-align: justify;\">Egg Allergy Key Products<\/p>\n<p style=\"text-align: justify;\">Egg Allergy- Unmet Needs<\/p>\n<p style=\"text-align: justify;\">Egg Allergy- Market Drivers and Barriers<\/p>\n<p style=\"text-align: justify;\">Egg Allergy- Future Perspectives and Conclusion<\/p>\n<p style=\"text-align: justify;\">Egg Allergy Analyst Views<\/p>\n<p style=\"text-align: justify;\">Egg Allergy Key Companies<\/p>\n<p style=\"text-align: justify;\">Appendix<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Deatiled TOC: https:\/\/www.delveinsight.com\/sample-request\/egg-allergy-pipeline-insight<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>About&nbsp;DelveInsight<\/strong><br \/> DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=egg-allergy-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-aimmune-therapeutics-dbv-technologies-asit-biotechand-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/egg-allergy-pipeline-insight\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/egg-allergy-pipeline-insight<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/egg-allergy-pipeline-insight\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=egg-allergy-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-aimmune-therapeutics-dbv-technologies-asit-biotechand-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Egg Allergy Pipeline Egg Allergy develops when immune system of the body becomes sensitized and overreacts to proteins in egg whites and\/or yolks. When eggs are eaten, the body recognizes the protein as a foreign substance and sends out chemicals &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/egg-allergy-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-aimmune-therapeutics-dbv-technologies-asit-biotechand-others_538782.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-538782","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/538782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=538782"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/538782\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=538782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=538782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=538782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}